Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes

AIM: To evaluate the PAQ (®) (CeQur SA, Horw, Switzerland), a wearable 3‐day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. METHOD: Adults with Type 2 diabetes with HbA(1c) concentrations ≥53 and ≤97 mmol/mol (7.0 and 11.0%) while t...

Full description

Saved in:
Bibliographic Details
Published in:Diabet Med
Main Authors: Mader, J. K., Lilly, L. C., Aberer, F., Poettler, T., Johns, D., Trautmann, M., Warner, J. L., Pieber, T. R.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175230/
https://ncbi.nlm.nih.gov/pubmed/29888811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13708
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items